Early Outcomes of Soft Tissue Sarcomas Presenting With Metastases and Treated With Chemotherapy

被引:12
作者
King, Joseph J. [2 ]
Fayssoux, Reginald S. [2 ]
Lackman, Richard D. [1 ]
Ogilvie, Christian M. [1 ]
机构
[1] Univ Penn, Dept Orthoped Surg, Philadelphia, PA 19106 USA
[2] Drexel Univ, Dept Orthoped Surg, Philadelphia, PA 19104 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2009年 / 32卷 / 03期
关键词
soft tissue sarcoma; metastasis; chemotherapy; resection; survival; LYMPH-NODE METASTASIS; PULMONARY METASTASECTOMY; PROGNOSTIC-FACTORS; SURVIVAL; RESECTION; CRITERIA; DISEASE;
D O I
10.1097/COC.0b013e318187dd6b
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The purpose of this study is to describe outcomes for patients with metastatic soft tissue sarcoma treated with chemotherapy. Methods: We retrospectively reviewed the records of 383 soft tissue sarcoma patients treated at our institution from 1997 to 2006. Thirty-five patients met the inclusion criteria-metastatic disease on presentation; primary tumor outside the abdomen; treatment with chemotherapy; and minimum follow-up of 3 months. Treatments were individualized and determined by a multidisciplinary oncology team. Patient survival was calculated from the diagnostic biopsy to the date of death or last follow-up using the Kaplan-Meier method. Results: Mean age was 47 years (range 17-74 years). Most common tumors involved were MFH and leiomyosarcoma. Sixteen of 35 (46%) patients had died at last follow-up. Mean patient survival was 24 months (range 4-102). The 2-year and 5-year survival rates were 64% and 24%, respectively. Twenty-nine patients (83%) presented with pulmonary metastasis, 6 with bone metastases (17%), 4 with regional node metastases (11%), and 4 with soft tissue metastases (11%). Survival was the same for those with pulmonary and only extrapulmonary metastases. The 10 patients with complete resection or complete chemotherapy response of all detectable lesions had longer mean survival (34 months) than the 25 patients who had partial/no resection or response (20 months) (P = 0.02). Conclusions: Soft tissue sarcoma patients presenting with metastatic disease have a low survival rate, but complete eradication of tumor correlated with longer survival. Longer-term studies especially those tracking the outcome of complete responders and those completely resected will help determine the efficacy of chemotherapy.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 31 条
[1]   Metastasectomy for limited metastases from soft tissue sarcoma [J].
Abdalla E.K. ;
Pisters P.W.T. .
Current Treatment Options in Oncology, 2002, 3 (6) :497-505
[2]   Monitoring referral and treatment in soft tissue sarcoma -: Study based on 1,851 patients from the Scandinavian Sarcoma Group Register [J].
Bauer, HCF ;
Trovik, CS ;
Alvegård, TA ;
Berlin, Ö ;
Erlanson, M ;
Gustafson, P ;
Klepp, R ;
Möller, TR ;
Rydholm, A ;
Sæter, G ;
Wahlström, O ;
Wiklund, T .
ACTA ORTHOPAEDICA SCANDINAVICA, 2001, 72 (02) :150-159
[3]   Prognosis of lymph node metastasis in soft tissue sarcoma [J].
Behranwala, KA ;
A'Hern, R ;
Omar, AM ;
Thomas, JM .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (07) :714-719
[4]   Pulmonary metastases from soft tissue sarcoma - Analysis of patterns of disease and postmetastasis survival [J].
Billingsley, KG ;
Burt, ME ;
Jara, E ;
Ginsberg, RJ ;
Woodruff, JM ;
Leung, DHY ;
Brennan, MF .
ANNALS OF SURGERY, 1999, 229 (05) :602-612
[5]  
CASSON AG, 1992, CANCER, V69, P662, DOI 10.1002/1097-0142(19920201)69:3<662::AID-CNCR2820690311>3.0.CO
[6]  
2-I
[7]   Survival after pulmonary metastasectomy in soft tissue sarcoma - Prognostic factors in 214 patients [J].
Choong, PFM ;
Pritchard, DJ ;
Rock, MG ;
Sim, FH ;
Frassica, FJ .
ACTA ORTHOPAEDICA SCANDINAVICA, 1995, 66 (06) :561-568
[8]  
Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO
[9]  
2-3
[10]   A CONTROLLED PILOT-STUDY OF HIGH-DOSE METHOTREXATE AS POSTSURGICAL ADJUVANT TREATMENT FOR PRIMARY OSTEO-SARCOMA [J].
EDMONSON, JH ;
GREEN, SJ ;
IVINS, JC ;
GILCHRIST, GS ;
CREAGAN, ET ;
PRITCHARD, DJ ;
SMITHSON, WA ;
DAHLIN, DC ;
TAYLOR, WF .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) :152-156